Advertisement

MDS Inc. (TSX:MDS) met analyst expectations for revenue at US$53 million in its fiscal third quarter but the restructured Canadian life sciences company reported a loss rather than a profit. The nuclear medicine imaging company's continuing operations lost US$15 million or 27 cents per share.

Advertisement
Advertisement